In vitro GBM cells with inactivated-mutant p53 were less susceptible to inhibitors targeting DNA repair [77], highlighting the mutant phenotype’s ability to accumulate mutations at a faster rate and to promote tumor growth. The gene discussed is TP53; the disease is neoplasm.